Start Date:7/15/2020 
Start Time:8:30 AM EDT 
Duration:180 minutes 
 
Abstract:
Join us for a virtual event featuring updates from management on our advancing cardiovascular pipeline and strategies to build a commercial franchise. Panel discussions will showcase perspectives from leading heart failure and HCM experts on the dynamic and evolving treatment landscape. Also learn from patients living with heart disease in an interactive discussion.  Company Speakers including: Robert Blum, Fady Malik, M.D., Ph.D., Stuart Kupfer, M.D., Andrew Wolff, M.D., Steve Heitner, M.D., Laura Robertson, M.D., Scott Jordan, Durga Bobba and Diane Weiser  Expert Speakers:
 - John McMurray, M.D., Professor of Medical Cardiology & Honorary Consultant Cardiologist, Institute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow
 - Adrian Hernandez, M.D., MHS, Executive Director, Duke Clinical Research Institute, Vice Dean, Duke University School of Medicine
 - Larry Allen, M.D., MHS, Professor of Medicine, Kenneth Poirier Chair; Associate Head for Clinical Affairs, Cardiology; Medical Director, Advanced Heart Failure, University of Colorado School of Medicine
 - Marty Maron, M.D., Director Hypertrophic Cardiomyopathy Center, Tufts Medical Center and Chanin T. Mast Hypertrophic Cardiomyopathy Center, Morristown Medical Center
 - Anjali Tiku Owens, M.D., Medical Director, Center for Inherited Cardiac Disease, Assistant Professor of Medicine, University of Pennsylvania
 - Andrew Wang, M.D., Professor of Medicine, Vice Chief for Clinical Services, Duke University School of Medicine
  Patient Speakers: Lindsay Davis, Linda Moczkowski  
 
If you're already registered for the Activate. Inhibit. Empower. Changing the Course of Cardiovascular Disease: A Cytokinetics Investor & Analyst Event  webcast, click below: 
ALREADY REGISTERED? 
 
 
Speakers
$-[WCSpeakerDisplayHTML]-$ 
 
 
  
  | 
    
      
  
    | 
       Activate. Inhibit. Empower. Changing the Course of Cardiovascular Disease: A Cytokinetics Investor & Analyst Event  
      Registration Is Closed 
     | 
   
           
     | 
     |